ISU Abxis Co., Ltd., a prominent player in the biotechnology sector, is headquartered in South Korea (KR) and operates extensively across Asia and beyond. Founded in 2004, the company has established itself as a leader in the development of innovative diagnostic solutions and therapeutic antibodies, catering to the growing demands of the healthcare industry. ISU Abxis is renowned for its cutting-edge products, including monoclonal antibodies and diagnostic kits, which are distinguished by their high specificity and reliability. The company’s commitment to research and development has led to significant advancements in immunology and molecular diagnostics, positioning it as a trusted partner in the global market. With a focus on quality and innovation, ISU Abxis continues to achieve notable milestones, solidifying its reputation as a key contributor to the biotechnology landscape.
How does ISU Abxis Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
ISU Abxis Co., Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
ISU Abxis Co., Ltd., headquartered in South Korea (KR), currently does not have available carbon emissions data for the most recent year. As a result, there are no specific figures regarding their total emissions, which would typically encompass Scope 1, Scope 2, and Scope 3 emissions. Additionally, ISU Abxis has not outlined any reduction targets or commitments related to climate initiatives, such as those from the Science Based Targets initiative (SBTi) or other recognised climate pledges. The absence of documented reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the lack of emissions data and formal commitments, ISU Abxis Co., Ltd. appears to have opportunities for enhancing its climate action framework and establishing measurable targets in line with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ISU Abxis Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.